The volume of the right (red) and left (blue) IC are shown as a function of age on a logarithmic scale. by Pingling Kwok (14896191)

DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx by Teresa Fontán-Baselga (20392470)

“…In addition, we observed a significant decrease in the number and size of astrocytes in both sexes and in the number of microglial cells in a sex-dependent manner. …”

Fig 2 - by Qingqing Hao (5464070)

Distribution of responses to vital signs. by Lisa Thiele (6468056)

“…However, barriers to consumer escalation decrease this potential. Interventions to increase consumer knowledge should therefore be accompanied by strategies to minimise barriers.…”

Survey tool development process. by Lisa Thiele (6468056)

“…However, barriers to consumer escalation decrease this potential. Interventions to increase consumer knowledge should therefore be accompanied by strategies to minimise barriers.…”

Respondent characteristics. by Lisa Thiele (6468056)

“…However, barriers to consumer escalation decrease this potential. Interventions to increase consumer knowledge should therefore be accompanied by strategies to minimise barriers.…”

Seven forecast scenarios. by Ryan P. Thombs (9138968)

“…We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …”

Forecast for each scenario, 2023-2032. by Ryan P. Thombs (9138968)

“…We find that a decrease in expenditures has a larger effect on decreasing energy consumption than an increase in expenditures does on increasing consumption. …”

S1 File - by Chantelle M. de Vet (16535257)

“…Moreover, the mean of those differences were significantly different for all trainees for LV-GLS (<i>p</i>_adj<0.001) and RV-GLS (<i>p</i>_adj = 0.029), and did significantly change over time for RV-GLS (<i>p</i>_adj<0.001) but not for LV-GLS.…”

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Flow diagram of the patient selection into the final analysis. by Zi-Rong Chen (9227618)

Subjects:

Patients’ demographics and clinical parameters. by Zi-Rong Chen (9227618)

Subjects:

Associations between demographic variables, In4_SED and SE changes at 6 and 12 months after 4_SED (<i><i>n</i></i> = 80). by Zi-Rong Chen (9227618)

Subjects:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects:

GLS analysis with 2D-STE software. by Chantelle M. de Vet (16535257)

“…Moreover, the mean of those differences were significantly different for all trainees for LV-GLS (<i>p</i>_adj<0.001) and RV-GLS (<i>p</i>_adj = 0.029), and did significantly change over time for RV-GLS (<i>p</i>_adj<0.001) but not for LV-GLS.…”

Column charts of SI_8min and SI_10min in the therapy and control group at follow-up. by Felix L. Herr (21544362)

Column charts of WiAUC in therapy and control group at baseline and follow-up. by Felix L. Herr (21544362)

Renal outcomes of both treatment groups. by Marwan El-Deyarbi (21688492)

“…Participants in the multifactorial group achieved a significant mean difference in low-density lipoprotein cholesterol levels (mean difference = −0.14, 95% CI: −0.27–0.001, P < 0.03), and significant adjusted mean difference of eGFR levels difference (3.93 mL/min/1.73 m², 95% CI: 1.27–6.58, P < 0.01) at study completion compared to those in the control group. …”

Mouse and human T-ALL samples show differential expression of genes involved in sensitivity to NAMPT inhibition. by Chelsea Vrana (21560473)

Mean muscle activation patterns across the gait cycle during walking with anteroposterior (AP) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke d... by Sanne Ettema (18786312)